Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients
ConclusionDermatomyositis patients with anti–NXP‐2 antibodies have a distinct and often severe systemic phenotype that includes myalgia, peripheral edema, and significant dysphagia, despite having milder inflammatory skin disease.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Anna Rogers, Lorinda Chung, Shufeng Li, Livia Casciola ‐Rosen, David F. Fiorentino Tags: Original Article Source Type: research
More News: Arthritis | Cancer & Oncology | Dermatology | Dermatomyositis | Laboratory Medicine | Rheumatology | Skin